¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Leprosy review."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® leprosy ÇÑ±Û ³ªº´
¼³¸í   
  ³ª±Õ¿¡ ÀÇÇÏ¿© °¨¿°µÇ´Â ¸¸¼º Àü¿°¼º ³­Ä¡º´. ÇǺο¡ »ìÁ¡ÀÌ ºÒ°ÅÁ® ³ª¿À°Å³ª ¹ÝÁ¡ °°Àº °ÍÀÌ »ý±â°í ±× ºÎºÐÀÇ Áö°¢ÀÌ ¸¶ºñµÇ¸ç ´«½çÀÌ ºüÁö°í ¼Õ¹ßÀ̳ª ¾ó±¼ÀÌ º¯ÇüµÇ¸ç ´«ÀÌ Àß º¸ÀÌÁö ¾Ê°Ô µÈ´Ù. ³ªº´Àº È£»ê¼º ¸·´ë±ÕÀΠ³ª±Õ¿¡ ÀÇÇÑ ¸¸¼º Àü¿°º´À¸·Î, ÁַΠÇǺο͠¸»ÃʽŰæÀ» Ä§¹üÇϴ º´ÀÌ´Ù. ´ëºÎºÐÀÌ Àεµ¿¡¼­ ¹ß°ßµÇÁö¸¸ ¿ì¸®³ª¶ó¿¡µµ Àִ º´ÀÌ´Ù. º´Çü ºÐ·ù·Î¼­, ³ªº´Á¾Çü, °áÇÙ³ªº´, °æ°è³ªº´ ±×¸®°í ºÎÁ¤³ªº´ÀÌ ÀÖ´Ù. °¨¿°Àº °í¸§, Ä๰, Ä§¿¡ Á÷Á¢ Á¢ÇÑ °æ¿ì¿¡ ³ªÅ¸³­´Ù. Áõ»óÀº ³ªº´Á¾ÇüÀº °áÀý, Ä§À±, È«¹Ý, Å»¸ðÀÌ°í °áÇÙ³ªº´ÇüÀº °æ°è°¡ ¸íÈ®ÇÑ È«¹Ý, ½Å°æÁõ»óÀ¸·Î¼­ Áö°¢ÀÌ»ó, ½Å°æºñÈÄ, ¶¡³²Àå¾Ö, ÆÈ´Ù¸®ÀÇ º¯ÇüÀÌ ÀϾ´Ù. ÀԾȿµ¿ª¿¡¼­´Â Çô, ÀÔ¼ú, ÀÕ¸ô¿¡ °áÀý¼º È«¹ÝÀ» ¾à 20% º¼ ¼ö ÀÖ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • drug utilization review
    ¾à¹°»ç¿ë°ËÅä
  • Institutional Review Board
    »ý¸íÀ±¸®À§¿øÈ¸
  • retrospective review
    ÈÄÇâÆò°¡
  • review
    °ËÅä, Æò°¡
  • review of system
    ü°èº°¹®Áø
  • borderline leprosy
    °æ°è³ªº´, Áß°£³ªº´
  • indeterminate leprosy
    ºÒÈ®Á¤³ªº´, ºÎÁ¤Çü³ªº´
  • lepromatous leprosy
    ³ªÁ¾Çü³ªº´, ³ªº´Á¾³ªº´
  • leprosy
    ³ªº´
  • leprosy control program
    ³ªº´°ü¸®»ç¾÷
  • multibacillary leprosy
    ´Ù±Õ³ªº´, ±Õ¸¹Àº³ªº´
  • macular leprosy
    ¹ÝÁ¡³ªº´
  • nodular leprosy
    °áÀý³ªº´
  • paucibacillary leprosy
    Èñ±Õ³ªº´, ±ÕÀûÀº³ªº´
  • reactional leprosy
    ¹ÝÀÀ¼º³ªº´
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leprosy
    ³ªº´
  • review
    °ËÅä, Æò°¡
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • concurrent review
    ÀÔ¿øÁßÁ¶»ç, µ¿½ÃÆò°¡
  • drug utilization review
    ¾à¹°»ç¿ë°ËÅä
  • review
    Á¶»ç, Æò°¡
  • retrospective review
    Åð¿øÈÄÁ¶»ç, »çÈÄÆò°¡
  • utilization review
    ÀÇ·áÀ̿뵵Á¶»ç
  • borderline leprosy
    °æ°è³ªº´, Áß°£³ªº´
  • indeterminate leprosy
    ºÎÁ¤³ªº´
  • leprosy
    ³ªº´
  • lepromatous leprosy
    ³ªº´Á¾³ªº´
  • leprosy control program
    ³ªº´°ü¸®»ç¾÷
  • macular leprosy
    ¹Ý»ó³ªº´
  • multibacillary leprosy
    ´Ù±Õ³ªº´
  • nodular leprosy
    °áÀý³ªº´
  • paucibacillary leprosy
    Èñ±Õ³ªº´
  • reactional leprosy
    ¹ÝÀÀ³ªº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • professional standard review organization(PSRO)
    ÀÇ·áÆò°¡¿ø.
  • Hansen disease = leprosy
    ÇѼ¾º´, ³ªº´
  • Leprosy
    ³ªº´(ÔýÜ»)
  • indeterminate leprosy
    ¹Ì<ºÎ>Á¤³ªº´(Ú±<ÝÕ>ïÒÑÛÜ»).
  • indeterminate leprosy
    ¹Ì<ºÎ>Á¤³ªº´(Ú±<ÝÕ>ïÒÑÛÜ»)
  • rat leprosy
    ÁãÀÇ ³ªº´(¡­ÑÛÜ»)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • concurrent review
    ÀÔ¿ø Áß Á¶»ç, µ¿½ÃÆò°¡
  • drug utilization review
    ¾à¹°»ç¿ë °ËÅä.
  • life review
    Àλý¹ÝÃß(ìÑßæÚãõÖ)
  • peer review
    µ¿·á Àç°Ë(î¢Ëþ)
  • peer review organization(PRO)
    µ¿·á½É»çÀ§¿øÈ¸.
  • professional standard review organization(PSRO)
    ÀÇ·áÆò°¡¿ø.
  • retrospective review
    Åð¿øÈÄ Á¶»ç, »çÈÄÆò°¡.
  • utilization review
    ÀÇ·áÀ̿뵵 Á¶»ç.
  • borderline leprosy
    °æ°èÇü³ª(º´)(ÌÑÍ£úþ Ü»), Áß°£±º³ª(º´)
  • borderline leprosy
    °æ°èÇü³ª(º´)(ÌÑÍ£úþ Ü»), Áß°£±º³ª(º´).
  • early leprosy
    Á¶±â³ª(º´).
  • histoid leprosy
    Á¶Á÷±¸¾ç ³ªº´
  • indeterminate leprosy
    ¹Ì<ºÎ>Á¤³ªº´(Ú±<ÝÕ>ïÒÑÛÜ»).
  • indeterminate leprosy
    ¹Ì<ºÎ>Á¤³ªº´(Ú±<ÝÕ>ïÒÑÛÜ»)
  • larynx, leprosy of the
    Èĵγªº´
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leprosy
    ³ª, ³ªº´
  • review
    Àç°í, °³¼³, ºñÆò, Æò·Ð, ȸ°í
  • review article
    Á¾¼³
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PRO peer review organization; physician review organization; Professional Review Organization; pronation...
ILA insulin-like activity; International Leprosy Association
LL large lymphocyte; lateral leminiscus; left lateral; left leg; left lower; left lung; lepromatous [in...
DUR drug use review; drug utilization review
MEDPAR Medical Provider Analysis and Review; Medicare Provider Analysis and Review
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LL Lepromatous leprosy
DUR Drug Use Review
DUR Drug Utilization Review
IRB Institutional Review Board
MEDPAR Medicare Provided Analysis and Review
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 5495
    JournalTitle: Leprosy review.
    MedAbbr: Lepr Rev
    ISSN: 0305-7518
    ESSN:
    IsoAbbr:
    NlmId: 243711
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • critical review
    ºñÆÇÀû °íÂû
  • drug utilization review
    ¾à¹° »ç¿ë °ËÅä
  • institinal review board

    institution (±â°ü, Á¦µµ

  • review article
    Á¾¼³
  • histoid leprosy
    Á¶Á÷±¸¾ç ³ªº´
  • indeterminate leprosy
    ¹ÌÁ¤ ³ªº´, ºÎÁ¤ ³ªº´
  • lepromatous leprosy
    ³ªÁ¾ ³ª
    ³ªº´Çü Áß¿¡¼­´Â °¡Àå ÁßÁõÇüÀÌ´Ù. ³ª±Õ¿¡ ´ëÇÑ ¼¼Æ÷¼º ¸é¿ªÀÌ ÀúÇϵǰí Àֱ⠶§¹®¿¡ ¿¹ÈÄ´Â ÁÁÁö ¾Ê´Ù. ±ÕÀÇ Áõ½ÄÀº ½ÉÇÏ´Ù.
  • leprosy
    ³ªº´, ³ª
    ÇǺÎ, Á¡¸·, ¸»ÃʽŰæ°è¿¡ ¿©·¯ °¡ÁöÀÇ À°¾ÆÁ¾¾ç º´º¯À» Çü¼ºÇÏ´Â ³ª±Õ¿¡ ÀÇÇØ ÀϾ´Â ¸¸¼ºÀÇ Àü¿°¼º Áúȯ. µÎ °¡Áö Çü
  • leprosy bacillus
    ³ª °£±Õ
    »ç¶÷ ³ª ȯÀÚÀÇ ÇǺΠº´¼Ò µµ¸» Ç¥º»À̳ª ±âŸ º´¸® Àç·á Áß¿¡ ±Õ ´Ù¹ß ¶Ç´Â ÀüÇüÀû ÀÀ±«·Î¼­ ´Ù¼ö ¹ß°ßµÇ´Â ¼¼±Õ.
  • leprosy control
    ³ª °ü¸®
    °³³ä»ó, ÁÖ¹ÎÀ» ³ª±ÕÀÇ Àü¿°À¸·ÎºÎÅÍ º¸È£ÇÏ´Â ¿¹¹æ °ü¸®¿Í, ³ªÈ¯ÀÚ¸¦ ³ª±ÕÀ¸·ÎºÎÅÍ ¿À´Â À°Ã¼Àû, Á¤½ÅÀû °íÅëÀ» ´ú¾î ÁÖ´Â Áø·á °ü¸®ÀÇ µÎ °¡Áö·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ¨ç ¿¹¹æ °ü¸®´Â Àü¿°¿øÀ» Â÷´ÜÇÏ´Â °ÍÀ» ¸»Çϴµ¥, ³ª ȯÀÚ¸¦ °Ý¸®ÇÔÀ¸·Î½á ³ªº´ÀÇ Àü¿°¿øÀÌ Â÷´ÜµÈ´Ù°í »ý°¢Çß´ø ½Ã´ë¿¡´Â ³ª ȯÀÚ Àü¿øÀ» °Ý¸® ¼ö¿ëÇÏ¿´´Ù. ±×·¯³ª Àüü ³ª ȯÀÚ Áß ±ØÈ÷ ÀϺÎÀÇ ¹Ì°ü¸®ÇÏ¿¡ Àִ ȯÀÚ¸¸ÀÌ Àü¿°¿øÀÌ µÈ´Ù´Â »ç½ÇÀÌ ¹àÇôÁø ¿À´Ã³¯¿¡´Â, ³ª ȯÀÚ·Î È®ÀÎÀÌ µÇ¾î ¾àÁ¦ Åõ¿©°¡ ½ÃÀÛµÈ ÈÄ¿¡´Â Àü¿°¿øÀÌ µÉ ¼ö ¾ø´Ù´Â °á·Ð¿¡ À̸£·¶´Ù. ÀÌ¿¡ µû¶ó ¿À´Ã³¯¿¡´Â ÀÏ¹Ý ÇǺΠÁúȯÀÚ¿Í °°ÀÌ ÀÚÀ¯·ÎÀÌ »ý¾÷¿¡ Á¾»çÇϸç Áø·á¸¦ ¹Þ°í ÀÖ´Ù. ¨è Áø·á °ü¸®´Â Àǻ簡 Á¤È®ÇÑ Áø´Ü°ú º´Çü ºÐ·ù¸¦ ¹ÙÅÁÀ¸·Î ÀûÇÕÇÑ Ã³¹æÀ» ³»¸®°í ȯÀÚ°¡ ¼º½ÇÇÏ°Ô ¾àÀ» º¹¿ëÇÏ´Â °ÍÀÌ´Ù. ¹®Á¦´Â ³ªº´ÀÌ ¸¸¼ºÀûÀ¸·Î °æ°úÇÏ´Â Àå±â ÁúȯÀε¥´Ù Ä¡·áÀÇ ¼º°ú°¡ Áï½Ã ³ªÅ¸³ªÁö ¾ÊÀ¸¹Ç·Î 󹿰ú º¹¾àÀÌ ³ªÅÂÇØÁ® Ä¡·á°¡ ºÒ±ÔÄ¢ÇØÁö°í ¾àÁ¦ ³»¼ºÀ» ¹ßÀü½ÃŰ´Â µ¥ µû¸¥ °ü¸®»óÀÇ ¾î·Á¿òÀÌ ÀÖ´Ù. ³ªº´¿¡ ´ëÇÑ Æí°ßÀ» ¾ø¾Ö°í ±¹¹ÎÀû ÀÌÇØ¿Í Âü¿©¿¡ ÀÇÇØ Á¶±â ¹ß°ß ¹× Ä¡·á¿¡ ÀÓÇÑ´Ù¸é ³ªº´ °ü¸®¸¦ À§ÇÑ Æ¯¼ö ½Ã¼³À̳ª ±â°üÀÌ ÇÊ¿ä¾ø°Ô µÉ °ÍÀÌ´Ù.
  • leprosy of the larynx
    ÈĵΠ³ªº´
    le
  • leprosy prevention act
    ³ªº´ ¿¹¹æ¹ý
  • multibacillary leprosy
    ´Ù±Õ ³ªº´
  • mutilating leprosy
    Àý´Ü ³ª
  • nodular leprosy
    °áÀý ³ª
    µ¿ÀǾî=tubercular le
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
rate setting and review A method of examining and setting levels of payments.
(12 Dec 1998)
peer review Scrutiny by one's peers (equals). Peer-reviewed articles appearing in medical journals have been scrutinised by members of the biomedical community before publication.
(12 Dec 1998)
peer review, health care The concurrent or retrospective review by practicing physicians or other health professionals of the quality and efficiency of patient care practices or services ordered or performed by other physicians or other health professionals .
(12 Dec 1998)
peer review, research The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions.
(12 Dec 1998)
review 1. A second or repeated view; a reexamination; a retrospective survey; a looking over again; as, a review of one's studies; a review of life.
2. An examination with a view to amendment or improvement; revision; as, an author's review of his works.
3. A critical examination of a publication, with remarks; a criticism; a critique.
4. A periodical containing critical essays upon matters of interest, as new productions in literature, art, etc.
5. An inspection, as of troops under arms or of a naval force, by a high officer, for the purpose of ascertaining the state of discipline, equipments, etc.
6. The judicial examination of the proceedings of a lower court by a higher.
7. A lesson studied or recited for a second time. Bill of review, a commission formerly granted by the crown to revise the sentence of the court of delegates.
Synonym: Reexamination, resurvey, retrospect, survey, reconsideration, revisal, revise, revision.
Origin: F. Revue, fr. Revu, p. P. Of revoir to see again, L. Revidere; pref. Re- re- + videre to see. See View, and cf. Revise.
Source: Websters Dictionary
(01 Mar 1998)
review, academic A more or less comprehensive review of the literature on a specific subject, with usually an extensive critical analysis and synthesis of the literature.
(12 Dec 1998)
review literature Published material which provides an examination of recent or current literature. Reviews can cover a wide range of subject matter of various levels of completeness or comprehensiveness based on analyses of publications on the subject. The review may reflect the state of the art. It also includes reviews as a literary form. The presence of research findings or case reports does not preclude designation as a review.
(12 Dec 1998)
review, multicase A type of review literature giving demographic, laboratory, and clinical data on a group of persons or animals ranging from most of the known cases of a rare condition in large populations on whom the results of research will lead to the establishing of epidemiological analyses or predictions of the occurrence and natural history of diseases. It is differentiated from review of reported cases in that the latter generally reports a single case as a supplement to a presentation, however brief and limited, of other cases known to have been reported.
(12 Dec 1998)
review of reported cases Literature reporting - to the best of the author's ability - all known cases of a disease. The study is usually generated by the investigator's encounter with patients with a given disease and includes the investigator's own cases. The range of time will encompass historical cases and recent cases. The review usually cites the literature in which the known cases were published and may or may not include clinical and laboratory data.
(12 Dec 1998)
review, tutorial A type of review citing literature that will give the user a general and reasonably thorough coverage of a subject with which he may or may not be familiar. It often substitutes as a refresher course for a physician to update his or her awareness or as a crash course for a student unfamiliar with the subject.
(12 Dec 1998)
physician payment review commission A commission created by the consolidated omnibus reconciliation act of 1985, enacted in 1986, and given the mandate to advise congress on medicare-physician payment. The commission members are appointed by the u.s. Office of technology assessment.
(12 Dec 1998)
concurrent review Review of the medical necessity of hospital or other health facility admissions, upon or within a short time following an admission, and periodic review of services provided during the course of treatment.
(12 Dec 1998)
professional review organizations Organizations representing designated geographic areas which have contracts under the pro program to review the medical necessity, appropriateness, quality, and cost-effectiveness of care received by medicare beneficiaries. Peer review improvement act, pl 97-248, 1982.
(12 Dec 1998)
scientific integrity review Designation for reports by the united states office of research integrity, identifying questionable research published in articles or books. Notification of the questionable data is carried in the nih guide for grants and contracts.
(12 Dec 1998)
drug utilization review Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for medicaid programs beginning in 1993.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leprosy
    ¹®µÐº´
  • leprosy
    ³ªº´
  • review
    ȸ°íÇÏ´Ù
  • book review
    ¼­Æò
  • review
    ÀçÁ¶»ç;ÀçÀ½¹Ì;°üÂû;ȸ°í;¹Ý¼º;°³°ü;Àü¸Á;°³¼³;º¹½À;¿¬½À;¿¬½À¹®Á¦;ºñÆò;³íÆò;Æò·Ð;Æò·ÐÀâÁö;½ÃÂû;¿­º´;»ç¿­;°üº´½Ä;°üÇÔ½Ä;Àç½É;=REVUE;´Ù½ÃÁ¶»çÇÏ´Ù;Á¤¹ÐÇÏ°Ô »ìÇÇ´Ù;°üÂûÇÏ´Ù;º¹½ÀÇÏ´Ù;ȸ°íÇÏ´Ù;ȸ»óÇÏ´Ù;(Ã¥µîÀ»)ºñÆò(³íÆò)ÇÏ´Ù;½ÃÂûÇÏ´Ù;°Ë¿­ÇÏ´Ù;¿­º´ÇÏ´Ù;Àç½ÉÇÏ´Ù;Æò
  • review order
    (¿­º´½ÄÀÇ)Á¤Àå;¿­º´´ëÇü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á